They thus proposed that the BARD1 gene hypomethylation, among epigenetic changes of 8 other genes, can be used as an identifier for the likelihood of HCC with predisposing risk in HBV-negative patients. The gene discussed is BARD1; the disease is hepatocellular carcinoma.